Kirsten B Kluivers Selected Research

Uterine Prolapse (Vaginal Prolapse)

1/2022	Risk factors for pelvic organ prolapse recurrence after sacrospinous hysteropexy or vaginal hysterectomy with uterosacral ligament suspension.
9/2019	Sacrospinous hysteropexy versus vaginal hysterectomy with uterosacral ligament suspension in women with uterine prolapse stage 2 or higher: observational follow-up of a multicentre randomised trial.
2/2016	The Impact of Sacrospinous Hysteropexy and Vaginal Hysterectomy With Suspension of the Uterosacral Ligaments on Sexual Function in Women With Uterine Prolapse: A Secondary Analysis of a Randomized Comparative Study.
7/2015	Sacrospinous hysteropexy versus vaginal hysterectomy with suspension of the uterosacral ligaments in women with uterine prolapse stage 2 or higher: multicentre randomised non-inferiority trial.
11/2009	The effectiveness of surgical correction of uterine prolapse: cervical amputation with uterosacral ligament plication (modified Manchester) versus vaginal hysterectomy with high uterosacral ligament plication.
6/2008	Vaginal prolapse repair surgery augmented by ultra lightweight titanium coated polypropylene mesh.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kirsten B Kluivers Research Topics

Disease

6	Pelvic Organ Prolapse 01/2022 - 11/2009
6	Uterine Prolapse (Vaginal Prolapse) 01/2022 - 06/2008
5	Prolapse 01/2022 - 06/2008
3	Urinary Incontinence 11/2020 - 07/2007
2	Pain (Aches) 11/2022 - 01/2021
2	Inflammation (Inflammations) 03/2022 - 11/2020
2	Endometrial Neoplasms (Endometrial Cancer) 01/2018 - 11/2011
2	Stress Urinary Incontinence 10/2016 - 05/2013
2	Wounds and Injuries (Trauma) 08/2015 - 07/2009
1	Pelvic Pain 11/2022
1	Neoplasms (Cancer) 01/2018
1	Growth Disorders 01/2017
1	Dyspareunia 10/2016
1	absence of Vagina 01/2015
1	Varicose Veins (Varicose Vein) 03/2012
1	Joint Instability (Joint Laxity) 03/2012
1	Endometrial Hyperplasia 11/2011
1	Infertility (Sterility) 07/2009
1	Infections 07/2009
1	Hemorrhage 07/2007
1	Abscess 07/2007

Drug/Important Bio-Agent (IBA)

4	SuspensionsIBA 01/2022 - 07/2015
2	Biological ProductsIBA 01/2017 - 07/2009
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 11/2022
1	Type A Botulinum Toxins (Botox)FDA Link 11/2022
1	Estrogen ReceptorsIBA 03/2022
1	Proteins (Proteins, Gene)FDA Link 11/2020
1	Nerve Growth Factor (NGF)IBA 11/2020
1	GlycosaminoglycansIBA 01/2017
1	Proteoglycans (Proteoglycan)IBA 01/2017
1	Collagen Type III (Type III Collagen)IBA 09/2014
1	CollagenIBA 03/2012
1	SolutionsIBA 11/2008
1	Polypropylenes (Polypropylene)IBA 06/2008
1	TitaniumIBA 06/2008

Therapy/Procedure

5	Vaginal Hysterectomy 01/2022 - 11/2009
5	Hysterectomy 01/2018 - 07/2007
3	Length of Stay 01/2018 - 07/2009
2	Pessaries 01/2022 - 09/2019
2	Suburethral Slings (Tension-Free Vaginal Tape) 01/2021 - 10/2016
2	Therapeutics 01/2015 - 05/2013
1	Injections 11/2022
1	Castration 01/2018
1	Salpingo-oophorectomy 11/2011
1	Surgical Amputation (Amputations) 11/2009
1	Endometrial Ablation Techniques 07/2007